Timber Hill’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-36,700
Closed -$1.26M 2833
2014
Q4
$1.26M Sell
36,700
-300
-0.8% -$9.78K 0.01% 1295
2014
Q3
$1.1M Buy
37,000
+18,900
+104% +$401K ﹤0.01% 1529
2014
Q2
$363K Buy
18,100
+6,900
+62% +$158K ﹤0.01% 2292
2014
Q1
$304K Buy
11,200
+100
+0.9% +$2.65K ﹤0.01% 2357
2013
Q4
$230K Sell
11,100
-32,500
-75% -$613K ﹤0.01% 2756
2013
Q3
$794K Buy
43,600
+8,300
+24% +$150K ﹤0.01% 2120
2013
Q2
$587K Buy
+35,300
New +$564K ﹤0.01% 2378

Other funds holding AUXL

Timber Hill's AUXL Position: Q3 2014 in Review

Timber Hill sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 13,454 shares — an estimated $285K sold.

Timber Hill first reported a position in AUXL in Q2 2013 and held it in 2 quarters. The position peaked at $945K in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Timber Hill reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Timber Hill sold 13,454 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $285K.
  • Timber Hill first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Timber Hill's AUXILIUM PHARAMCEUTICALS INC position peaked at $945K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Timber Hill's 13F filing for Q3 2014, filed 24 Nov 2014.